JMS Co

JMS Co EBITDA per Employee

The EBITDA per Employee of JMS Co (7702.T) as of Nov 2, 2026 is 67,787.61 JPY. In the previous year, EBITDA per Employee was 235,221.24 JPY — a change of -71.18% (lower).

EBITDA per Employee

67,787.61JPY

YoY

-71.18%

Last updated:

EBITDA per Employee of JMS Co is 2026 67,787.61 JPY. EBITDA per Employee of JMS Co was 2025 235,221.24 JPY. It decreases by -71.18% lower compared to the previous year.

The JMS Co EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2019
318,407.08 JPY
Jan 1, 2020
503,362.83 JPY
Jan 1, 2021
465,486.73 JPY
Jan 1, 2022
241,415.93 JPY
Jan 1, 2023
203,893.81 JPY
Jan 1, 2024
135,398.23 JPY
Jan 1, 2025
235,221.24 JPY
Jan 1, 2026
67,787.61 JPY
The JMS Co EBITDA per Employee history
YEAREBITDA per EmployeeYoY
67,787.61JPY-71.18%
235,221.24JPY+73.73%
135,398.23JPY-33.59%
203,893.81JPY-15.54%
241,415.93JPY-48.14%
465,486.73JPY-7.52%
503,362.83JPY+58.09%
318,407.08JPY+39.13%
228,849.56JPY-13.05%
263,185.84JPY-18.92%
324,601.77JPY+127.54%
142,654.87JPY-38.43%
231,681.42JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JMS Co Stock analysis

What does JMS Co do? JMS Co., Ltd. generates revenue through the manufacture, sale, export, and import of medical devices and pharmaceuticals across its five geographical segments: Japan, Singapore, China, Philippines, and Germany. The company offers a range of products including infusion and nutrition products, dialysis products, surgery products, blood and cell products, and other related items. Key products such as infusion & transfusion sets, syringe pumps, surgical gowns, dialysis kits, peritoneal dialysate, microcatheters, and blood bags are sold to healthcare providers and institutions within these regions. The firm also provides maintenance services and other related services as part of its product portfolio. The company's primary customers are healthcare providers and institutions in Japan, Singapore, China, Philippines, and Germany, where it operates through its five geographical segments. These customers purchase medical equipment and drugs, including specific items like infusion & transfusion sets, dialysis kits, and surgical gowns. The firm's product lines are tailored to meet the needs of hospitals, clinics, and other medical facilities across its operational regions. JMS Co., Ltd. focuses on manufacturing and selling medical equipment and drugs, with a strong emphasis on products such as infusion & transfusion sets, syringe pumps, surgical gowns, and dialysis kits. The company's revenue streams are driven by the sale of these products and the provision of maintenance services. Its geographical segments ensure a diversified market presence, allowing it to serve various healthcare sectors in different countries. JMS Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JMS Co stock

EBITDA per Employee of JMS Co is 67,787.61 JPY in 2026.

EBITDA per Employee of JMS Co changed from 235,221.24 JPY to 67,787.61 JPY, representing a -71.18% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee JMS Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's JMS Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — JMS Co

All Key Metrics — JMS Co